Join
today
Boliven PRO is more than just patent search
- Build and save lists using the powerful Lists feature
- Analyze and download your search results
- Share patent search results with your clients
Patents »
US6273912: Flanged graft for end-to-side anastomosis
Filing Information
Patent Family
6 Claims, 3 Drawings
Abstract
An expanded polytetrafluoroethylene flanged vascular graft (10) suitable for end-to-side anastomosis grafting having an integral terminal polytetrafluoroethylene flanged skirt or cuff section (12) which facilitates an end-to-side anastomosis directly between an artery and the expanded polytetrafluoroethylene flanged bypass graft (10) without need for an intervening venous collar or venous patch.
- 1. A vascular graft suitable for end-to-side anastomosis, comprising:
an expanded polytetrafluoroethylene tubular graft member having proximal and distal ends; and
at least one flanged section comprised of expanded polytetrafluoroethylene which projects outwardly away from a central axis of the tubular graft member at the distal end of the tubular graft member, the at least one flanged section being a continuous and integral section of the tubular graft member, wherein the at least one flanged section further comprises two flange members projecting outwardly away from the central axis of the tubular graft member in opposing directions.
- 2. A vascular graft suitable for end-to-side anastomosis, comprising:
an expanded polytetrafluoroethylene tubular graft member having proximal and distal ends; and
at least one flanged section comprised of expanded polytetrafluoroethylene which projects outwardly away from a central axis of the tubular graft member at the distal end of the tubular graft member, the at least one flanged section being a continuous and integral section of the tubular graft member, wherein the at least one flanged section further comprises two flange members projecting outwardly away from the central axis of the tubular graft member in opposing directions, wherein the two flange members are substantially symmetrical mirror-images of one another.
- 3. A vascular graft suitable for end-to-side anastomosis, comprising:
an expanded polytetrafluoroethylene tubular graft member having proximal and distal ends; and
at least one flanged section comprised of expanded polytetrafluoroethylene which projects outwardly away from a central axis of the tubular graft member at the distal end of the tubular graft member, the at least one flanged section being a continuous and integral section of the tubular graft member, wherein the at least one flanged section further comprises two flange members projecting outwardly away from the central axis of the tubular graft member in opposing directions, wherein the two flange members are substantially asymmetrical to one another.
- 4. A vascular graft suitable for end-to-side anastomosis, comprising:
an expanded polytetrafluoroethylene tubular graft member having proximal and distal ends; and
at least one flanged section comprised of expanded polytetrafluoroethylene which projects outwardly away from a central axis of the tubular graft member at the distal end of the tubular graft member, the at least one flanged section being a continuous and integral section of the tubular graft member, wherein the at least one flanged section further comprises two flange members projecting outwardly away from the central axis of the tubular graft member in opposing directions, wherein a first of the two flange members comprises a toe section of the graft oriented distally relative to a fluid flow through the bypass graft and the second of the two flange members comprises a heel section of the graft oriented proximally relative to a fluid flow through the graft.
- 5. A vascular graft suitable for end-to-side anastomosis, comprising:
an expanded polytetrafluoroethylene tubular graft member having proximal and distal ends;
at least one flanged section comprised of expanded polytetrafluoroethylene which projects outwardly away from a central axis of the tubular graft member at the distal end of the tubular graft member, the at least one flanged section being a continuous and integral section of the tubular graft member, wherein the at least one flanged section further comprises two flange members projecting outwardly away from the central axis of the tubular graft member in opposing directions, wherein a first of the two flange members comprises a toe section of the graft oriented distally relative to a fluid flow through the bypass graft and the second of the two flange members comprises a heel section of the graft oriented proximally relative to a fluid flow through the graft; and
a crotch angle formed at a junction point between the first and second flange members, the crotch angle being between 45° and 180°.
- 6. A vascular graft suitable for end-to-side anastomosis, comprising:
an expanded polytetrafluoroethylene tubular graft member having proximal and distal ends; and
at least one flanged section comprised of expanded polytetrafluoroethylene which projects outwardly away from a central axis of the tubular graft member at the distal end of the tubular graft member, the at least one flanged section being a continuous and integral section of the tubular graft member, wherein the at least one flanged section further comprises two flange members projecting outwardly away from the central axis of the tubular graft member in opposing directions, wherein a first of the two flange members comprises a toe section of the graft oriented distally relative to a fluid flow through the bypass graft and the second of the two flange members comprises a heel section of the graft oriented proximally relative to a fluid flow through the graft, wherein the first and second flange members each have a length between 1 to 5 times a lumenal diameter of the expanded polytetrafluoroethylene graft member.
References Cited
U.S. Patent Documents
Foreign Patent Documents
| Document Number | Assignees | Inventors | Issue/Pub Date |
| WO199600103 | | | Jan 1996 |
* cited by examiner
Other Publications
| Justin H. Miller et al. “The Use of the Vein Cuff and PTFE”, Vascular Surgical Techniques and Atlas Second Edition, pp. 276-286. |
| R.S. Taylor et al. “Improved Tecnique for Polytetrafluoroethylene Bypass Grafting: Long-Term Results Using Anastomotic Vein Patches”, The British Journal of Surgery. 1992, vol. 79, Apr. 4, 1992, pp. 348-354. |
| J.F. Chester et al. “Interposition Vein Patches for Vascular Reconstruction”, pp. 1-3. |
| John H.N. Wolfe “Polytetrafluoroethylene (PTFE) Femorodistal Bypass”, Rob & Smiths Operative Surgery/Vascular Surgery Fifth Edition, pp. 330-340. |
Referenced By
| Document Number | Assignee | Inventors | Issue/Pub Date |
|
FR2850008
|
ROUX DANIEL
|
ROUX DANIEL
|
Jul 2004
|
|
EP1576928
|
Markus Enzler
|
Markus Enzler
|
Sep 2005
|
|
US7500978
|
Intrinsic Therapeutics, Inc.
|
Bogomir Gorensek et al.
|
Mar 2009
|
|
US7507243
|
|
Gregory Lambrecht et al.
|
Mar 2009
|
|
US6936072
|
Intrinsic Therapeutics, Inc.
|
Gregory Lambrecht et al.
|
Aug 2005
|
|
US7553329
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
Jun 2009
|
|
US7553330
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
Jun 2009
|
|
US7553316
|
Bard Peripheral Vascular, Inc.
|
Hans Scholz et al.
|
Jun 2009
|
|
US6582463
|
Heartstent Corporation
|
David H. Mowry et al.
|
Jun 2003
|
|
US7008436
|
BARATH PETER
|
Peter Barath
|
Mar 2006
|
|
US7513911
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
Apr 2009
|
|
US7563282
|
Intrinsic Therapeutics, Inc.
|
Greg H. Lambrecht et al.
|
Jul 2009
|
|
US7867278
|
Intrinsic Therapeutics, Inc.
|
Greg H. Lambrecht et al.
|
Jan 2011
|
|
US7879097
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
Feb 2011
|
|
US7658765
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
Feb 2010
|
|
US7717961
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
May 2010
|
|
US7727241
|
Intrinsic Therapeutics, Inc.
|
Bogomir Gorensek et al.
|
Jun 2010
|
|
US7749275
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht et al.
|
Jul 2010
|
|
US7524333
|
Intrinsic Therapeutics, Inc.
|
Greg H. Lambrecht et al.
|
Apr 2009
|
|
US7959679
|
Intrinsic Therapeutics, Inc.
|
Greg H. Lambrecht et al.
|
Jun 2011
|
|
US7972337
|
Intrinsic Therapeutics, Inc.
|
Thomas Boyajian et al.
|
Jul 2011
|
|
US8002836
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht
|
Aug 2011
|
|
US7998213
|
Intrinsic Therapeutics, Inc.
|
Greg H. Lambrecht et al.
|
Aug 2011
|
|
US8025698
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht
|
Sep 2011
|
|
US8021425
|
Intrinsic Therapeutics, Inc.
|
Gregory H. Lambrecht
|
Sep 2011
|
|
US8066758
|
C. R. Bard, Inc.
|
David L. Bogert et al.
|
Nov 2011
|
|
US8114082
|
Intrinsic Therapeutics, Inc.
|
Thomas Boyajian et al.
|
Feb 2012
|
|
US8231678
|
Intrinsic Therapeutics, Inc.
|
Gregory Lambrecht
|
Jul 2012
|
|
US8257437
|
Intrinsic Therapeutics, Inc.
|
Greg H. Lambrecht et al.
|
Sep 2012
|
|
US8313524
|
C. R. Bard, Inc.
|
Tarun J. Edwin et al.
|
Nov 2012
|
|
US8323341
|
Intrinsic Therapeutics, Inc.
|
Gregory Lambrecht et al.
|
Dec 2012
|
Boliven’s Predicted Expiration Date includes in its calculation the number of days of patent term adjustment a U.S. patent is entitled. The Predicted Expiration Date does not, currently, include in its calculation the payment of maintenance fees, the filing of any disclaimer(s), and/or patent term extension, but Boliven is working to include this information in the near future.